1.
Bioorg Med Chem Lett
; 26(18): 4492-4496, 2016 09 15.
Artículo
en Inglés
| MEDLINE
| ID: mdl-27499454
RESUMEN
Features from a high throughput screening (HTS) hit and a previously reported scaffold were combined to generate 1,7-naphthyridones as novel KDM5 enzyme inhibitors with nanomolar potencies. These molecules exhibited high selectivity over the related KDM4C and KDM2B isoforms. An X-ray co-crystal structure of a representative molecule bound to KDM5A showed that these inhibitors are competitive with the co-substrate (2-oxoglutarate or 2-OG).